OBJECTIVE: To investigate if development of skeletal muscle fatigue during repeated voluntary biceps contractions could be attenuated by low-level laser therapy (LLLT). BACKGROUND DATA: Previous animal studies have indicated that LLLT can reduce oxidative stress and delay the onset of skeletal muscle fatigue. MATERIALS AND METHODS:Twelve male professional volleyball players were entered into a randomized double-blind placebo-controlled trial, for two sessions (on day 1 and day 8) at a 1-wk interval, with both groups performing as many voluntary biceps contractions as possible, with a load of 75% of the maximal voluntary contraction force (MVC). At the second session on day 8, the groups were either given LLLT (655 nm) of 5 J at an energy density of 500 J/cm2 administered at each of four points along the middle of the biceps muscle belly, or placebo LLLT in the same manner immediately before the exercise session. The number of muscle contractions with 75% of MVC was counted by a blinded observer and blood lactate concentration was measured. RESULTS: Compared to the first session (on day 1), the mean number of repetitions increased significantly by 8.5 repetitions (+/- 1.9) in the active LLLT group at the second session (on day 8), while in the placebo LLLT group the increase was only 2.7 repetitions (+/- 2.9) (p = 0.0001). At the second session, blood lactate levels increased from a pre-exercise mean of 2.4 mmol/L (+/- 0.5 mmol/L), to 3.6 mmol/L (+/- 0.5 mmol/L) in the placebo group, and to 3.8 mmol/L (+/- 0.4 mmol/L) in the active LLLT group after exercise, but this difference between groups was not statistically significant. CONCLUSION: We conclude that LLLT appears to delay the onset of muscle fatigue and exhaustion by a local mechanism in spite of increased blood lactate levels.
RCT Entities:
OBJECTIVE: To investigate if development of skeletal muscle fatigue during repeated voluntary biceps contractions could be attenuated by low-level laser therapy (LLLT). BACKGROUND DATA: Previous animal studies have indicated that LLLT can reduce oxidative stress and delay the onset of skeletal muscle fatigue. MATERIALS AND METHODS: Twelve male professional volleyball players were entered into a randomized double-blind placebo-controlled trial, for two sessions (on day 1 and day 8) at a 1-wk interval, with both groups performing as many voluntary biceps contractions as possible, with a load of 75% of the maximal voluntary contraction force (MVC). At the second session on day 8, the groups were either given LLLT (655 nm) of 5 J at an energy density of 500 J/cm2 administered at each of four points along the middle of the biceps muscle belly, or placebo LLLT in the same manner immediately before the exercise session. The number of muscle contractions with 75% of MVC was counted by a blinded observer and blood lactate concentration was measured. RESULTS: Compared to the first session (on day 1), the mean number of repetitions increased significantly by 8.5 repetitions (+/- 1.9) in the active LLLT group at the second session (on day 8), while in the placebo LLLT group the increase was only 2.7 repetitions (+/- 2.9) (p = 0.0001). At the second session, blood lactate levels increased from a pre-exercise mean of 2.4 mmol/L (+/- 0.5 mmol/L), to 3.6 mmol/L (+/- 0.5 mmol/L) in the placebo group, and to 3.8 mmol/L (+/- 0.4 mmol/L) in the active LLLT group after exercise, but this difference between groups was not statistically significant. CONCLUSION: We conclude that LLLT appears to delay the onset of muscle fatigue and exhaustion by a local mechanism in spite of increased blood lactate levels.
Authors: Kelly A Larkin-Kaiser; Evangelos Christou; Mark Tillman; Steven George; Paul A Borsa Journal: J Athl Train Date: 2014-11-14 Impact factor: 2.860
Authors: Ana Lúcia Borges de Souza Faria; Luis Augusto Lupato Conrado; Luiz Sergio Vanzela; Antonio Balbin Villaverde; Egberto Munin Journal: Lasers Med Sci Date: 2017-07-17 Impact factor: 3.161
Authors: Larissa Aline Santos; Rodrigo Labat Marcos; Shaiane Silva Tomazoni; Adriane Aver Vanin; Fernanda Colella Antonialli; Vanessa dos Santos Grandinetti; Gianna Móes Albuquerque-Pontes; Paulo Roberto Vicente de Paiva; Rodrigo Álvaro Brandão Lopes-Martins; Paulo de Tarso Camillo de Carvalho; Jan Magnus Bjordal; Ernesto Cesar Pinto Leal-Junior Journal: Lasers Med Sci Date: 2014-03-21 Impact factor: 3.161
Authors: Eliane Martins Amadio; Andrey Jorge Serra; Simone A Guaraldo; José Antônio Silva; Ednei Luis Antônio; Flávio Silva; Leslie Andrews Portes; Paulo José Ferreira Tucci; Ernesto Cesar Pinto Leal-Junior; Paulo de Tarso Camillo de Carvalho Journal: Lasers Med Sci Date: 2015-02-03 Impact factor: 3.161
Authors: Mateus Rossato; Rodolfo A Dellagrana; Fábio J Lanferdini; Raphael L Sakugawa; Caetano D Lazzari; Bruno M Baroni; Fernando Diefenthaeler Journal: Lasers Med Sci Date: 2016-06-06 Impact factor: 3.161
Authors: Tanupriya Agrawal; Gaurav K Gupta; Vikrant Rai; James D Carroll; Michael R Hamblin Journal: Dose Response Date: 2014-09-22 Impact factor: 2.658